Approximately 60% of CagriSema-treated participants achieved at least 20% weight loss, and 40.4% achieved at least 25% loss, with some participants losing over 30% of body weight
Annu Rev Med , 2004, 55: 395-417
Furthermore, unlike long-acting GLP-1 analogs that also signal through the incretin pathway, DPP-4 inhibitors do not require parenteral administration, and their long-term use is associated with a low risk of gastrointestinal adverse effects and no meaningful increases in heart rate [37,38,39,40]
Melatonin and circadian rhythms
"Since its a relatively new medication, your insurance company may want you to first try another treatment for sleep apnea, like a continuous positive airway pressure (CPAP) machine," Wojeck says